Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 15 04:33
Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.
Feb 14 09:06
Aridis Pharmaceuticals | 8-K: Current report
Jan 16 13:00
Aridis Pharmaceuticals | DEFA14A: Others
Dec 18, 2023 22:43
Aridis Pharmaceuticals | 8-K: Current report
Dec 18, 2023 22:40
Aridis Pharmaceuticals | DEFA14A: Others
Dec 16, 2023 06:00
Aridis Pharmaceuticals: Q3 2023 Earnings Report
Nov 7, 2023 05:06
Aridis Pharmaceuticals | 8-K: Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Nov 4, 2023 05:00
Aridis Pharmaceuticals | DEFA14A: Others
Nov 3, 2023 18:15
Aridis Pharmaceuticals | ARS: Annual Report to Security Holders
Nov 3, 2023 05:54
Aridis Pharmaceuticals | DEF 14A: Definitive information statements
Nov 3, 2023 05:51
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
Sep 20, 2023 04:05
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
Sep 20, 2023 04:05
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Patzer Eric
Sep 20, 2023 04:05
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truong Vu
Sep 20, 2023 04:05
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jafri Hasan
Sep 20, 2023 04:05
Aridis Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
Sep 14, 2023 09:47
Aridis Pharmaceuticals | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Sep 8, 2023 22:13
Aridis Pharmaceuticals | 8-K: Current report
Sep 8, 2023 04:15
Aridis Pharmaceuticals | 8-K: Current report
Aug 26, 2023 04:05
No Data
No Data